As you grow older, age-related stiffness and discomfort in the joints becomes a fact of life. Activities once routine become a challenge as limited mobility hampers your every move.
You now have a more potent option to provide broad-spectrum support for aging joints. ArthroMax® Advanced with UC-II® and AprèsFlex® is a multi-nutrient formula based on the very latest data on natural support for joint health. This ArthroMaxâ„¢ formula provides more joint support with two innovative, clinically validated ingredients: AprèsFlex® and UC-II®.
AprèsFlex® represents a quantum leap forward in the delivery of boswellia to aging joints. Long prized for its ability to help inhibit inflammatory factors, boswellia is especially effective at inhibiting the 5-LOX (5-lipoxygenase) enzyme.
Excess activity of 5-LOX results in the accumulation of leukotriene B4, a pro-inflammatory compound that affects aging joints. Boswellia has been shown to bind directly to the 5-LOX enzyme, preventing it from facilitating production of pro-inflammatory leukotrienes.69,70
AprèsFlex® boswellia absorbs into the blood 52% better than previously available forms of boswellia, for superior effectiveness.71
In addition to AprèsFlex®, this ArthroMax® formulation contains a standardized chicken cartilage called UC-II®. Data shows it supports immune health, joint comfort and ease of motion in aging individuals.
SUPPLEMENT FACTS
Serving Size 2 capsules | Servings Per Container 30 | | Amount Per Serving | Glucosamine sulfate 2KCI (derived from corn) | 1500 mg | AprèsFlex® Indian frankincense (Boswellia serrata) extract (gum resin) [std. to 20% AKBA? (20 mg)] | 100 mg | UC-II® standardized cartilage | 40 mg | Total Collagen | 10 mg | Boron (calcium fructoborate as patented FruiteX B® OsteoBoron®) | 1.5 mg | Other ingredients: vegetable cellulose (capsule), potassium chloride, microcrystalline cellulose, vegetable stearate, silica. |
Non-GMO ?3-O-acetyl-11-keto-ß-boswellic acid UC-II® is a registered trademark of InterHealth N.I. (U.S. Patents 7,846,487, 7,083,820 and EPO Patent EP1435906B1; Canadian Patent CA 2459981C; and Japanese Patent JP 4800574B2).
AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas - Laila NUTRA LLC. U.S. Patent No. 8,551,496 and other patents pending.
FruitX B® and OsteoBoron® are registered trademarks of VDF FutureCeuticals, Inc. U.S. Patent No. 5,962,049. |
| Dosage and Use |
- Take two (2) capsules daily with food, or as recommended by a healthcare practitioner.
|
Warnings - KEEP OUT OF REACH OF CHILDREN
- DO NOT EXCEED RECOMMENDED DOSE
- Do not purchase if outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
|
[ITEMPRICE]